← ANALYST RATINGS · TIPRANKS
Healthequity (HQY): analyst forecast and price target
Analyst consensus
Strong Buy5 Buy0 Hold0 Sell
Ratings of 5 analysts in the last 3 months · top analysts only12-month forecast
Based on 5 price targets given in the last 3 months, the average target is $120, the highest $142, the lowest $108. The average is +30.4% from the last price of $92.03.
Analyst ratings 16
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% | Bank of America Securities | $125 | Buy | +35.8% | Reiterated | 16.10.26on TipRanks 06:35 | +0.6% | ↗ |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $108 | Buy | +17.4% | Reiterated | 06.10.26on TipRanks 21:45 | +1.2%next day +1.7% · 5 days −1.2% | ↗ |
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $106 → $97.00−8.5% | Buy | +5.4% | Reiterated | 30.09.26on TipRanks 12:05 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $106 → $96.00−9.4% | Buy | +4.3% | Reiterated | 30.09.26on TipRanks 12:05 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $105 → $97.00−7.6% | Buy | +5.4% | Reiterated | 30.09.26on TipRanks 12:05 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $103 → $97.00−5.8% | Buy | +5.4% | Reiterated | 30.09.26on TipRanks 12:05 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $107 → $98.00−8.4% | Buy | +6.5% | Reiterated | 30.09.26on TipRanks 12:05 | — | |
| AI PerPlexity Medical - Healthcare Information ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $108 → $98.00−9.3% | Buy | +6.5% | Reiterated | 30.09.26on TipRanks 12:05 | — | |
| Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% | Wells Fargo | $125 | Buy | +35.8% | Assigned | 29.09.26on TipRanks 06:10 | −1.2%next day +1.6% · 5 days +2.4% | ↗ |
| Peter Warendorf★★★★★★★★★★#2259 · hits 83% · avg +21.9% | Barclays | $110 → $115+4.5% | Buy | +25.0% | Reiterated | 18.09.26on TipRanks 05:20 | +0.5%next day −2.2% · 5 days −8.5% | ↗ |
| George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% | Deutsche Bank | $135 → $142+5.2% | Buy | +54.3% | Assigned | 31.08.26on TipRanks 08:40 | +0.5%next day +1.2% · 5 days −3.2% | ↗ |
| Alexander Paris★★★★★★★★★★#153 · hits 66% · avg +20.2% | Barrington | $110 | Buy | +19.5% | Reiterated | 28.08.26on TipRanks 09:30 | +3.4%next day +0.5% · 5 days −0.4% | ↗ |
| Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% | BMO Capital | $105 | Buy | +14.1% | Reiterated | 28.08.26on TipRanks 07:15 | +3.4%next day +0.5% · 5 days −0.4% | ↗ |
| David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% | BTIG | $115 | Buy | +25.0% | Reiterated | 28.08.26on TipRanks 06:09 | +3.4%next day +0.5% · 5 days −0.4% | ↗ |
| Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% | Bank of America Securities | $125 | Buy | +35.8% | Reiterated | 28.08.26on TipRanks Aug 27 22:25 | +3.4%next day +0.5% · 5 days −0.4% | ↗ |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $108 | Buy | +17.4% | Reiterated | 27.08.26on TipRanks Aug 28 07:35 | −11.2%next day +3.4% · 5 days +5.5% | ↗ |
| Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% | KeyBanc | $125 | Buy | +35.8% | Reiterated | 18.08.26on TipRanks 05:25 | +1.1%next day +0.9% · 5 days +2.7% | ↗ |
| Alexei Gogolev★★★★★★★★★★#2483 · hits 54% · avg +6.0% | J.P. Morgan | $123 | Buy | +33.7% | Reiterated | 25.06.26on TipRanks 08:15 | −2.0%next day +6.8% · 5 days +12.8% | ↗ |
| Constantine Davides★★★★★★★★★★#12158 · hits 36% · avg −12.7% | Citizens JMP | $110 → $111+0.9% | Buy | +20.6% | Reiterated | 01.06.26on TipRanks 05:50 | +2.7%next day −2.7% · 5 days −0.5% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $88.00 | Sell | −4.4% | Reiterated | 29.05.26on TipRanks 09:15 | −3.0%next day +2.7% · 5 days +3.3% | ↗ |
| Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% | Jefferies | $120 → $108−10.0% | Buy | +17.4% | Reiterated | 19.02.26on TipRanks 13:45 | +2.6%next day −0.7% · 5 days −2.6% | ↗ |
| Gregory Peters★★★★★★★★★★#411 · hits 67% · avg +10.6% | Raymond James | $120 → $100−16.7% | Buy | +8.7% | Reiterated | 17.02.26on TipRanks 05:50 | +0.5%next day +3.2% · 5 days +1.4% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Healthequity
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $119 at a price of $88.46 (+34.4%); now: $119 at $92.03 (+29.2%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 0 | 0 | 0 | 0 | 0 |
| Buy | 12 | 10 | 12 | 13 | 12 | 11 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 08.12.26 (Q3 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.15 (from $1.13 to $1.19). Last quarter: $1.24.
Sales
Next quarter’s sales estimate — $347M (from $345M to $350M). Last quarter: $351M.
Best top-analyst consensus in the sector · Healthcare
About Healthequity
- CEO: Scott R. Cutler
- Employees: 2,814
- 15 West Scenic Pointe Drive, Draper, UT, 84020, US
- www.healthequity.com
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.
Data from the stock’s TipRanks forecast page, read 52 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗